Evidence map›Paper›PMID 37989873›Full record

ArticleScientific reports2023

Extracellular vesicles of human glial cells exert neuroprotective effects via brain miRNA modulation in a rat model of traumatic brain injury.

Diana I Salikhova, Angelika V Timofeeva, Victoria V Golovicheva, Timur Kh Fatkhudinov, Yulia A Shevtsova, Anna G Soboleva, Ivan S Fedorov, Kirill V Goryunov, Alexander S Dyakonov, Victoria O Mokrousova and 7 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 7 institutions in 1 country.

Diana I SalikhovaInstitute of Molecular and Cellular Medicine, Medical Institute, RUDN University, Moscow, Russian Federation, 117198. diana_salikhova@bk.ru.
Angelika V TimofeevaV.I. Kulakov National Medical Research Center of Obstetrics, Gynecology and Perinatology, Moscow, Russian Federation, 117997.
Victoria V GolovichevaA.N. Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Moscow, Russian Federation, 119992.
Timur Kh FatkhudinovInstitute of Molecular and Cellular Medicine, Medical Institute, RUDN University, Moscow, Russian Federation, 117198.
Yulia A ShevtsovaV.I. Kulakov National Medical Research Center of Obstetrics, Gynecology and Perinatology, Moscow, Russian Federation, 117997.
Anna G SobolevaInstitute of Molecular and Cellular Medicine, Medical Institute, RUDN University, Moscow, Russian Federation, 117198.
Ivan S FedorovV.I. Kulakov National Medical Research Center of Obstetrics, Gynecology and Perinatology, Moscow, Russian Federation, 117997.
Kirill V GoryunovV.I. Kulakov National Medical Research Center of Obstetrics, Gynecology and Perinatology, Moscow, Russian Federation, 117997.
Alexander S DyakonovResearch Centre for Medical Genetics, Moscow, Russian Federation, 115522.
Victoria O MokrousovaResearch Centre for Medical Genetics, Moscow, Russian Federation, 115522.
Margarita O ShedenkovaInstitute of Molecular and Cellular Medicine, Medical Institute, RUDN University, Moscow, Russian Federation, 117198.
Andrey V ElchaninovAvtsyn Research Institute of Human Morphology of Federal State Budgetary Scientific Institution "Petrovsky National Research Centre of Surgery", Moscow, Russian Federation, 117418.
Oleg V MakhnachResearch Centre for Medical Genetics, Moscow, Russian Federation, 115522.
Sergey I KutsevResearch Centre for Medical Genetics, Moscow, Russian Federation, 115522.
Vladimir P ChekhoninThe Serbsky State Scientific Center for Social and Forensic Psychiatry, Moscow, Russian Federation, 119034.
Denis N SilachevA.N. Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Moscow, Russian Federation, 119992. silachevdn@belozersky.msu.ru.
Dmitry V GoldshteinInstitute of Molecular and Cellular Medicine, Medical Institute, RUDN University, Moscow, Russian Federation, 117198.
Research Centre for Medical Genetics · RUNational Medical Research Center for Obstetrics, Gynecology and Perinatology named after Academician V.I.Kulakov of the Ministry of Healthcare of the Russian Federation · RULomonosov Moscow State University · RUPeoples' Friendship University of Russia · RUResearch Institute of Human Morphology · RUInstitute of Molecular and Cell Biology · RUMoscow Research and Clinical Center for Neuropsychiatry · RU

Funding

Russian Science Foundation 22-25-00354
6 · The paper itself

Abstract

Stem cell-based therapeutic approaches for neurological disorders are widely studied. Paracrine factors secreted by stem cells in vitro and delivered intranasally might allow bypassing the disadvantages associated with a surgical cell delivery procedure with likely immune rejection of a transplant. In this study, we investigated the therapeutic effect of the extracellular vesicles secreted by glial progenitor cells (GPC-EV) derived from human induced pluripotent stem cell in a traumatic brain injury model. Intranasal administration of GPC-EV to Wistar rats for 6 days improved sensorimotor functions assessed over a 14-day observation period. Beside, deep sequencing of microRNA transcriptome of GPC-EV was estimate, and was revealed 203 microRNA species that might be implicated in prevention of various brain pathologies. Modulation of microRNA pools might contribute to the observed decrease in the number of astrocytes that inhibit neurorecovery processes while enhancing neuroplasticity by decreasing phosphorylated Tau forms, preventing inflammation and apoptosis associated with secondary damage to brain tissue. The course of GPC-EV administration was promoted the increasing protein levels of NF-κB in studied areas of the rat brain, indicating NF-κB dependent mechanisms as a plausible route of neuroprotection within the damaged area. This investigation showed that GPC-EV may be representing a therapeutic approach in traumatic brain injury, though its translation into the clinic would require an additional research and development.

Indexed as

Brain Injuries, TraumaticExtracellular VesiclesInduced Pluripotent Stem CellsMicroRNAsNeuroprotective AgentsAnimalsBrainHumansNeurogliaNF-kappa BRatsRats, WistarMicroRNAsNeuroprotective AgentsNF-kappa B

Identifiers

PMID37989873
PMCPMC10663567
OpenAlexW4388854228

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.